Abstract
Data for the first 12 months are reported for an ongoing, multicentre, clinical study comparing the long-term, ocular hypotensive efficacy and safety of topical levobunolol (0.5% and 1%) and timolol (0.5%). This study was a double-masked trial testing 88 patients with chronic open angle glaucoma or ocular hypertension. During the 12-month period drops were instilled twice daily into both eyes after a washout of prestudy ocular hypotensive medication. The effect of the three treatments in reducing intraocular pressure (IOP) was similar. Mean IOP reductions over the 12 months averaged 7.2 mmHg for the 0.5% levobunolol group, 6.2 mmHg for the 1% levobunolol group, and 6.0 mmHg for the timolol group. Decreases in mean heart rate of up to 5 beats per minute were observed in the 0.5% levobunolol group, up to 8 beats per minute in the 1% levobunolol group, and up to 4 beats per minute in the timolol group. Several patients were removed from the study owing to side effects possibly related to levobunolol treatment.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Duzman E., Ober M., Scharrer A., Leopold I. H. A clinical evaluation of the effects of topically applied levobunolol and timolol on increased intraocular pressure. Am J Ophthalmol. 1982 Sep;94(3):318–327. doi: 10.1016/0002-9394(82)90357-9. [DOI] [PubMed] [Google Scholar]
- Mills K. B. Blind randomised non-crossover long-term trial comparing topical timolol 0.25% with timolol 0.5% in the treatment of simple chronic glaucoma. Br J Ophthalmol. 1983 Apr;67(4):216–219. doi: 10.1136/bjo.67.4.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Partamian L. G., Kass M. A., Gordon M. A dose-response study of the effect of levobunolol on ocular hypertension. Am J Ophthalmol. 1983 Feb;95(2):229–232. doi: 10.1016/0002-9394(83)90018-1. [DOI] [PubMed] [Google Scholar]
- Steinert R. F., Thomas J. V., Boger W. P., 3rd Long-term drift and continued efficacy after multiyear timolol therapy. Arch Ophthalmol. 1981 Jan;99(1):100–103. doi: 10.1001/archopht.1981.03930010102012. [DOI] [PubMed] [Google Scholar]
- Van Buskirk E. M. Adverse reactions from timolol administration. Ophthalmology. 1980 May;87(5):447–450. doi: 10.1016/s0161-6420(80)35215-9. [DOI] [PubMed] [Google Scholar]